OM vs. INMD, IRMD, TNDM, KMTS, EMBC, SIBN, BBNX, AXGN, BVS, and SMLR
Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include InMode (INMD), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Kestra Medical Technologies (KMTS), Embecta (EMBC), SiBone (SIBN), Beta Bionics (BBNX), AxoGen (AXGN), Bioventus (BVS), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.
Outset Medical vs. Its Competitors
Outset Medical (NASDAQ:OM) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.
InMode has higher revenue and earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.
Outset Medical presently has a consensus price target of $24.67, suggesting a potential upside of 84.77%. InMode has a consensus price target of $18.04, suggesting a potential upside of 27.23%. Given Outset Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Outset Medical is more favorable than InMode.
InMode has a net margin of 44.50% compared to Outset Medical's net margin of -82.06%. InMode's return on equity of 18.38% beat Outset Medical's return on equity.
Outset Medical has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Comparatively, InMode has a beta of 1.93, meaning that its stock price is 93% more volatile than the S&P 500.
68.0% of InMode shares are held by institutional investors. 2.4% of Outset Medical shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
In the previous week, Outset Medical had 1 more articles in the media than InMode. MarketBeat recorded 5 mentions for Outset Medical and 4 mentions for InMode. InMode's average media sentiment score of 1.43 beat Outset Medical's score of 0.33 indicating that InMode is being referred to more favorably in the news media.
Summary
InMode beats Outset Medical on 11 of the 16 factors compared between the two stocks.
Get Outset Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Outset Medical Competitors List
Related Companies and Tools
This page (NASDAQ:OM) was last updated on 8/20/2025 by MarketBeat.com Staff